Somatus, a pioneering healthcare organization dedicated to accelerating health equity, has successfully raised $325 million in its latest funding round. With a mission to provide no-cost, high-quality kidney and heart care to eligible patients, Somatus is on the frontline of transforming the landscape of chronic disease management. This remarkable funding will empower the company to expand its innovative care delivery model, which integrates comprehensive medical and social services, ensuring that patients receive personalized, holistic treatment tailored to their unique needs. The fresh capital will also support the expansion of Somatus' technology platform, further enhancing its ability to gather insights and deliver data-driven care. As the prevalence of kidney and heart diseases continues to rise, Somatus is positioned to make a significant impact on the health and well-being of underserved populations across the United States. This investment is not just a testament to Somatus' commitment to improving health equity; it represents a significant stride towards a future where all patients have access to the high-quality care they deserve. With this funding, Somatus is poised to continue its journey in breaking down barriers to healthcare access and improving health outcomes, one patient at a time. As they embark on this new chapter, Somatus reaffirms its dedication to not only treating chronic conditions but also empowering individuals to lead healthier, more fulfilling lives. The team is excited to leverage this funding to further its mission and drive meaningful change in the communities it serves.
Revolutionizing Healthcare: Somatus Secures $325 Million in Funding to Expand Access to Quality Kidney and Heart Care
Get the full Somatus company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Picogrid
Picogrid is a technology company that builds products to integrate mission-critical systems. Its hardware and software products connect sensors, unmanned platforms, and digital systems, enabling unified control and data flow in defense and industrial environments. Deployed globally and supported by leading Silicon Valley investors, Picogrid delivers infrastructure for mission execution across land, sea, air, and space. Learn more at picogrid.com.
$45.0M Series a
today
XCENA
At our core, XCENA is driven by a singular mission: to pioneer fundamental technologies that will usher in a data-centric computing world. Our focus is on delivering cutting-edge solutions tailored to meet the needs of customers in sectors with large-scale data to process such as AI Big Data, Vector Databases, DNA Analysis, and on. Our expertise lies in the development of intelligent memory solutions and data-centric computing architecture, with a foundation built on Compute Express Link (CXL) standards. Through relentless innovation and strategic partnerships, we are dedicated to pushing the boundaries of what's possible in the realm of memory technology. Founded in 2022, XCENA is headquartered in Pangyo, South Korea. We are a dynamic team comprising experts in memory solutions with data domain-specific architecture, drawn from industry giants such as Samsung Electronics and SK hynix. Join us on this exciting journey as we redefine the future of computing through groundbreaking advancements in data-centric solutions! #MemorySolutions #DataCentric #Innovation #Technology #Computing #CXL #IntelligentMemory
$135.0M Series b
today
EarthOptics
EarthOptics is transforming how the world understands and manages soil. By combining next-generation sensors, advanced algorithms, and carbon analytics, we’re building the Soil Cloud—a powerful data platform that empowers farmers to sustainably optimize their operations, increase yields, and feed a growing global population. Our technology delivers high-resolution insights into soil properties at scale, making a positive impact on both environmental health and farm profitability.
$110.0M Series c
today
Otomato.xyz
Meet your Smart DeFi assistant. One setup, zero dashboards. Get hyper-targeted updates on your positions, starting with HyperEVM. ✨
$2.0M Seed
today
Waypoint Bio
Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.
$20.0M Series a
today